Audax Private Equity (Audax), in partnership with management, has completed the sale of Preferred Compounding Corporation (Preferred Compounding) to HEXPOL (STO:HPOL-B). Headquartered in Copley, OH, Preferred is a leading provider of proprietary and custom mixed rubber compounds, including strips, slabs, pellets, and calendered sheet end forms. The Company maintains relationships
Chicago-based private equity firm CORE Industrial Partners’ (CORE) portfolio company Prototek has acquired Cal-X, a provider of precision machining and sheet metal fabrication rapid prototyping services. Financial terms of the transaction have not been disclosed. Headquartered in Wisconsin, Cal-X offers rapid prototyping and short-run production services through its wide
Signavio, a provider of business transformation solutions, has announced a USD177 million investment to fuel continued international expansion and further investment in its world-class software suite. The transaction was led by Apax Digital, the growth equity team of Apax Partners, with participation from DTCP. Existing investor Summit Partners will retain an
Maven Capital Partners (Maven), has led a GBP900,000 investment in supercomputing technology specialist, ebb3 Limited (ebb3’). A total of GBP750,000 was invested by NPIF – Maven Equity Finance (NPIF), managed by Maven and part of the Northern Powerhouse Investment Fund, with a further GBP150,000 provided by the Maven VCTs. The
Frontier Development Capital (FDC), an established fund manager operating debt funds in England, has relocated its Birmingham headquarters. The firm has moved its operations and 25 staff from Baskerville House to a 5,246 sq ft office on 45 Church Street in the heart of the city’s business district. FDC
The Kempen European Private Equity Fund has acquired a significant direct interest in Wilvo Group a family business in the province of Brabant in the Netherlands that specialises in the processing of thin sheet metal and precision parts assembly. Wilvo Group employs 230 people and has an annual turnover of
vasopharm, a private biopharmaceutical company developing a new treatment for traumatic brain injury (TBI), has completed a EUR9.5 million financing co-led by HeidelbergCapital Private Equity and EF Investments. Existing investors Bayern Kapital, Future Capital, clients of Hanseatic Asset Management and Ringtons Holdings also participated in the round. In addition, vasopharm
Private equity manager Keensight Capital has acquired Infarco’s majority stake in 3P Biopharmaceuticals, a Contract Development and Manufacturing Organisation (CDMO) specialised in the process development and GMP manufacturing of biologics. Founded in 2006 and based near Pamplona, Spain, 3P Biopharmaceuticals offers a complete biologics production service, from preclinical and clinical
Private equity firm Permira is to acquire a majority stake in sustainable fashion brand Reformation. As part of the transaction, Yael Aflalo will remain Chief Executive Officer and a significant owner of the company, and Hali Borenstein will remain as President. Headquartered in Los Angeles and founded in 2009, Reformation
CEE private equity firm Innova Capital is to acquire Optiplaza, one of the major players in the Romanian optical market. The transaction marks further stronger entry of the fund into the attractive and growing optical market. The funds managed by Innova Capital have signed an agreement to acquire 100 per
12 November, 2026 – 5:00 pm
12 November, 2026 – 8:00 am
12 February, 2026 – 8:00 am
12 February, 2026 – 5:00 pm
